Valuation: Evotec SE

Market Cap 613M 709M 576M 523M 983M 67.6B 1B 6.75B 2.64B 33.93B 2.66B 2.6B 113B P/E 2026 *
-2.94x
P/E 2027 * -8.01x
Enterprise Value 755M 874M 711M 646M 1.21B 83.37B 1.23B 8.32B 3.25B 41.84B 3.28B 3.21B 139B EV / Sales 2026 *
1.26x
EV / Sales 2027 * 1.08x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-2.87%
1 week-0.52%
Current month+1.06%
1 month-1.71%
3 months-25.38%
6 months-44.29%
Current year-36.77%
1 week 3.41
Extreme 3.414
3.88
1 month 3.38
Extreme 3.38
3.88
Current year 3.18
Extreme 3.176
6.73
1 year 3.18
Extreme 3.176
7.3
3 years 3.18
Extreme 3.176
23.44
5 years 3.18
Extreme 3.176
45.83
10 years 3.18
Extreme 3.176
45.83
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO - 01/05/2026
Chief Operating Officer - 01/05/2026
Director TitleAgeSince
Director/Board Member 58 19/06/2019
Director/Board Member 64 01/06/2021
Director/Board Member 59 10/06/2024
Date Insider Type Main position Quantity % Market Cap.
1/30/26 A Fiscal year

Chief Technology Officer

6,760 0.0038%
1/30/26 A Tax

Chief Technology Officer

3,653 0.0021%
12/9/25 A Buy

Chairman

20,000 0.0113%
Change 5-day change 1-year change 3-year change Capi.($)
-2.87%-0.52%-45.78%-83.91% 709M
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
-0.59%-2.06%+26.35%+118.09% 16.15B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
Average -0.89%+0.39%+64.26%+88.87% 26.39B
Weighted average by Cap. -0.92%+0.59%+95.42%+132.33%

Financials

2026 *2027 *
Net sales 600M 694M 564M 512M 962M 66.18B 979M 6.6B 2.58B 33.21B 2.6B 2.55B 111B 719M 832M 677M 615M 1.15B 79.37B 1.17B 7.92B 3.1B 39.83B 3.12B 3.05B 133B
Net income -236M -273M -222M -202M -378M -26.03B -385M -2.6B -1.02B -13.06B -1.02B -1B -43.47B -60.37M -69.85M -56.79M -51.59M -96.89M -6.66B -98.57M -665M -260M -3.34B -262M -256M -11.13B
Net Debt 143M 165M 134M 122M 229M 15.77B 233M 1.57B 615M 7.91B 620M 607M 26.33B 162M 188M 153M 139M 260M 17.9B 265M 1.79B 698M 8.98B 704M 689M 29.89B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,461
Date Price Change Volume
14/08/26 €3.446 -2.87% 1,114,708
13/08/26 €3.548 -7.84% 1,592,879
12/08/26 €3.850 +3.89% 703,552
11/08/26 €3.706 +1.37% 623,911
10/08/26 €3.656 +5.54% 1,474,753
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
3.446EUR
Average target price
4.300EUR
Spread / Average Target
+24.78%

Quarterly revenue - Rate of surprise